189 related articles for article (PubMed ID: 32564300)
1. High detection sensitivity and reliable morphological correlation of PET with a silicon photomultiplier for primary tongue squamous cell carcinoma.
Kojima I; Takanami K; Ogawa T; Sakamoto M; Nagai H; Miyashita H; Iikubo M
Ann Nucl Med; 2020 Sep; 34(9):643-652. PubMed ID: 32564300
[TBL] [Abstract][Full Text] [Related]
2. High diagnostic accuracy for lymph node metastasis of oral squamous cell carcinoma using PET/CT with a silicon photomultiplier.
Kojima I; Takanami K; Ogawa T; Ishikawa K; Morishita Y; Ishii R; Ohkoshi A; Nakanome A; Odagiri H; Iikubo M
Oral Radiol; 2022 Oct; 38(4):540-549. PubMed ID: 35061164
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the maximum standardized uptake value of fluoro-2-deoxyglucose-positron emission tomography/computed tomography and clinicopathological characteristics in tongue squamous cell carcinoma.
Zheng D; Niu L; Liu W; Zheng C; Yan R; Gong L; Dong Z; Fei J; Li K
J Cancer Res Ther; 2019; 15(4):842-848. PubMed ID: 31436241
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of physiological FDG uptake in small structures between silicon photomultiplier-based PET and conventional PET.
Watanabe S; Hirata K; Magota K; Takenaka J; Wakabayashi N; Shinyama D; Yasuda K; Homma A; Kudo K
Ann Nucl Med; 2024 Feb; 38(2):131-138. PubMed ID: 37943379
[TBL] [Abstract][Full Text] [Related]
6. FDG PET using SUV
Huang YC; Lu HI; Huang SC; Hsu CC; Chiu NT; Wang YM; Chiu YC; Li SH
BMC Med Imaging; 2017 Jan; 17(1):1. PubMed ID: 28056868
[TBL] [Abstract][Full Text] [Related]
7. Is 18F-fluorodeoxyglucose positron emission tomography/computed tomography helpful in the decision-making process for neck dissection in patients with T1-T2 lingual cancer?
Shinohara S; Kikuchi M; Suehiro A; Kishimoto I; Harada H
Acta Otolaryngol; 2015 Feb; 135(2):181-6. PubMed ID: 25539188
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Results of a Prospective Trial to Compare
Baratto L; Toriihara A; Hatami N; Aparici CM; Davidzon G; Levin CS; Iagaru A
Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34070751
[TBL] [Abstract][Full Text] [Related]
10. (18)F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma.
Yokobori Y; Toyoda M; Sakakura K; Kaira K; Tsushima Y; Chikamatsu K
Acta Otolaryngol; 2015 May; 135(5):494-9. PubMed ID: 25739639
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
12. PET/MRI-guided GTV delineation during radiotherapy planning in patients with squamous cell carcinoma of the tongue.
Samołyk-Kogaczewska N; Sierko E; Zuzda K; Gugnacki P; Szumowski P; Mojsak M; Burzyńska-Śliwowska J; Wojtukiewicz MZ; Szczecina K; Jurgilewicz DH
Strahlenther Onkol; 2019 Sep; 195(9):780-791. PubMed ID: 31214735
[TBL] [Abstract][Full Text] [Related]
13. Initial experience with a PET/computed tomography system using silicon photomultiplier detectors.
Park SY; Barrato L; Hatami N; Davidzon G; Gambhir SS; Iagaru A
Nucl Med Commun; 2019 Nov; 40(11):1174-1178. PubMed ID: 31568189
[TBL] [Abstract][Full Text] [Related]
14. Exploration of tumor size measurement methods in preoperative breast cancer assessment using whole-body silicon photomultiplier PET: feasibility and first results.
Kuroda H; Yoshizako T; Yada N; Kamimura T; Yamamoto N; Maruyama M; Yoshida R; Fukuda M; Kataoka Y; Itakura M; Kaji Y
Jpn J Radiol; 2024 Jun; 42(6):639-647. PubMed ID: 38345725
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma.
Lee SJ; Choi JY; Lee HJ; Baek CH; Son YI; Hyun SH; Moon SH; Kim BT
Korean J Radiol; 2012; 13(6):752-9. PubMed ID: 23118574
[TBL] [Abstract][Full Text] [Related]
16. PET/CT findings and dose distribution during radiotherapy in T1N0M0-T2N0M0 glottic cancer.
Okada Y; Zama T; Itonaga T; Mikami R; Okubo M; Sugahara S; Kurooka M; Nakai M; Abe K; Yoshimura M; Saito K
Hell J Nucl Med; 2024; 27(1):27-34. PubMed ID: 38678383
[TBL] [Abstract][Full Text] [Related]
17. Is F-18 FDG PET/computed tomography a useful tool to restage the patients with tongue carcinoma?
Jain TK; Singh G; Goyal S; Malhotra H; Yadav A; Kumbhaj P; Yadav D; Khunteta N
Nucl Med Commun; 2021 Apr; 42(4):429-436. PubMed ID: 33306624
[TBL] [Abstract][Full Text] [Related]
18. Prognostic values of ADC
Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
[TBL] [Abstract][Full Text] [Related]
19. Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer.
Han MW; Lee HJ; Cho KJ; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
Head Neck; 2012 Oct; 34(10):1395-402. PubMed ID: 22052623
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison of brain [
Wagatsuma K; Sakata M; Ishibashi K; Hirayama A; Kawakami H; Miwa K; Suzuki Y; Ishii K
EJNMMI Phys; 2020 Nov; 7(1):70. PubMed ID: 33226451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
